Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth [7]

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 8, 2003, Pages 788-789

  Lamont, Ronald F ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; PLACEBO;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; GENITAL SYSTEM; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; HYSTERECTOMY; LACTATION; LETTER; ORGANISM COLONY; PREMATURE LABOR; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; UREAPLASMA UREALYTICUM; VAGINA FLORA; VAGINITIS;

EID: 0042700155     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2003.01040.x     Document Type: Letter

References (6)

1. Vermeulen GM, van Zwet AA, Bruinse HW. Changes in the vaginal flora after two percent Clindamycin vaginal cream in women at high risk of preterm birth. Br J Obstet Gynaecol 2001;108:697-700.
2. Mason MR, Adinkra PE, Lamont RF. Prophylactic administration of Clindmaycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased risk: a randomised placebo controlled double blind trial [letter]. Br J Obstet Gynaecol 2000;107:295-296.
3. Lamont RF. Infection in preterm labour. Proceedings of the 40th Study Group of the Royal College of Obstetrians and Gynaceologists, 2001.
4. Hay PE, Morgan DJ, Ison CA, et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994;101:1048-1053.
5. Carey JC, Klebanoff MD, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Materno-fetal Medicine Units. N Engl J Med 2000;342:534-540.
6. Lamont RF, Taylor-Robinson D, Hay PE. The ORACLE collaborative study [letter]. Lancet 2001. In press.